Di-(2-ethylhexyl) phthalate and autism spectrum disorders

ASN Neuro

Volumn 4, Issue 4, 2012, Pages 223-229

  Testa, Chiara ^a,b   Nuti, Francesca ^b   Hayek, Joussef ^c   de Felice, Claudio ^c   Chelli, Mario ^b   Rovero, Paolo ^b   Latini, I Giuseppe ^d,e   Papini, Anna Maria ^a,b  

^a UNIVERSITÉ DE CERGY PONTOISE   (France)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

^d PERRINO HOSPITAL   (Italy)

^e CNR   (Italy)

Author keywords

Autism; Di (2 ethylhexyl) phthalate; Endocrine disrupters; HPLC ESI MS urine analysis; Secondary metabolites

Indexed keywords

DICARBOXYLIC ACID; MONO (2 ETHYL 5 HYDROXYHEXYL) 1,2 BENZENEDICARBOXYLATE; MONO (2 ETHYL 5 OXOHEXYL) 1,2 BENZENEDICARBOXYLATE; MONO (2 ETHYL 6 HYDROXYHEXYL) 1,2 BENZENEDICARBOXYLATE; MONO (2 ETHYLHEXENYL) 1,2 BENZENEDICARBOXYLATE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; CHILD; CHILDHOOD AUTISM RATING SCALE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OXIDATION; PSYCHOLOGICAL RATING SCALE; RETT SYNDROME; SCHOOL CHILD; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADOLESCENT; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETHYLHEXYL PHTHALATE; ELECTROCHEMISTRY; FEMALE; HUMANS; MALE; NORMAL DISTRIBUTION; PHTHALIC ACIDS; ROC CURVE; TIME FACTORS;

EID: 84862666080     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1042/AN20120015     Document Type: Article

References (46)

1. Albro PM (1986) Absorption, metabolism, and excretion of di(2-ethylhexyl) phthalate by rats and mice. Environ Health Perspect 65:293-298.
2. Alcaro MC, Paolini I, Lolli F, Migliorini P, Rovero P, Papini AM (2009) Peptide contribution to the diagnosis of autoimmune diseases. Chemistry Today 27:11-14.
3. Anney RJL, Kenny EM, O'Dushlaine C, Yaspan BL, Parkhomenka E, Buxbaum JD, Sutcliffe J, Gill M, Gallagher D (2011) Gene-ontology enrichment analysis in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders. Eur J Hum Genet 19:1082-1089.
4. Bauer ML, Herrmann R (1997) Estimation of the environmental contamination by phthalic acid esters leaching from household wastes. Sci Total Environ 208:49-57.
5. Blount BC, Milgram KE, Silva MJ, Malek NA, Reidy JA, Needham LL, Brock JW (2000) Quantitative detection of eight phthalate metabolites in human urine using HPLC-APCIMS/MS. Anal Chem 72:4127-4134.
6. Chauhan V, Chauhan A, Cohen IL, Brown WT, Sheikh A (2004) Alteration in amino-glycerophospholipids levels in the plasma of children with autism: a potential biochemical diagnostic marker. Life Sci 74:1635-1643.
7. Cho SC, Bhang SY, Hong YC, Shin MS, Kim BN, Kim JW, Yoo HJ, Cho IH, Kim HW (2010) Relationship between environmental phthalate exposure and the intelligence of school-age children. Environ Health Perspect 118:1027-1032.
8. Clark-Taylor T, Clark-Taylor BE (2004) Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses 62:970-975.
9. De Felice C, Ciccoli L, Leoncini S, Signorini C, Rossi M, Vannuccini L, Guazzi G, Latini G, Comporti M, Valacchi G, Hayek J (2009) Systemic oxidative stress in classic Rett syndrome. Free Radical Biol Med 47:440-448.
10. Geschwind DH (2011) Genetics of autism spectrum disorders. Trends Cogn Sci 15:409-16.
11. Griffiths WC, Camara P, Lerner KS (1985) Bis-(2-ethylhexyl)phthalate, an ubiquitous environmental contaminant. Ann Clin Lab Sci 15:140-151.
12. Hellerstedt WL, McGovern PM, Fontaine P, Oberg CN, Cordes JE (2008) Prenatal environmental exposures and child health: Minnesota's role in the National Children's Study. Minn Med 91:40-43.
13. Herbert M (2010) Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol 23:103-110.
14. Hines EP, Calafat AM, Silva MJ, Mendola P, Fenton SE (2009) Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women. Environ Health Perspect 117:86-92.
15. Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC (2007) Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod 22:2715-2722.
16. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611-1617.
17. Kato K, Silva MJ, Needham LL, Calafat AM (2005) Determination of 16 phthalate metabolites in urine using automated sample preparation and on-line preconcentration/high-performance liquid chromatography/tandem mass spectrometry. Anal Chem 77:2985-2991.
18. Kato K, Silva MJ, Reidy JA, Hurtz D III, Malek NA, Needham LL, Nakazawa H, Barr DB, Calafat AM (2004) Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ Health Perspect 112:327-330.
19. Kim BN, Cho SC, Kim Y, Shin MS, Yoo HJ, Kim JW, Yang YH, Kim HW, Bhang SY, Hong YC (2009) Phthalates exposure and attention-deficit/hyperactivity disorder in school-age children. Biol Psychiatry 66:958-963.
20. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee HK, Song DH, Grinker RR (2011) Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry 168:904-912.
21. Koch HM, Preuss R, Angerer J (2006) Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int J Androl 29:155-165.
22. Koch HM, Rossbach B, Drexler H, Angerer J (2003) Internal exposure of the general population to DEHP and other phthalates-determination of secondary and primary phthalate monoester metabolites in urine. Environ Res 93:177-185.
23. Larsson M, Weiss B, Janson S, Sundell J, Bornhag CG (2009) Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6-8 years of age. Neurotoxicology 30:822-831.
24. Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P (2003). In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ Health Perspect 111:1783-1785.
25. Latini G, Verzotti A, De Felice C (2004) Di-2-ethylhexylphthlate and endocrine disruption: a review. Curr Drug Targets Immune Endocr Metabol Disord 4:37-40.
26. Latini G, Wittassek M, Del Vecchio A, Presta G, De Felice C, Angerer J (2009) Lactational exposure to phthalates in Southern Italy. Environ Int 35:236-239.
27. Mazzeo P, Di Pasquale D, Ruggieri F, Fanelli M, D'Archivio AA, Carlucci G (2007) HPLC with diode-array detection for the simultaneous determination of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in seminal plasma. Biomed Chromatogr 21:1166-1171.
28. Nelson KB (1991) Prenatal and perinatal factors in the etiology of autism. Pediatrics 87:761-766.
29. Nuti F, Hildenbrabd S, Chelli M, Wodarz R, Papini AM (2005) Synthesis of DEHP metabolites as biomarkers for GC-MS evaluation of phthalates as endocrine disrupters. Bioorg Med Chem 13:3461-3465.
30. Papini AM (2009) The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases. J Pept Sci 15:621-628.
31. Pecorelli A, Ciccoli L, Signorini C, Leoncini S, Giardini A, D'Esposito M, Filosa S, Pecorelli A, Valacchi G, Hayek J (2011) Increased levels of 4HNE-protein plasma adducts in Rett syndrome. Clin Biochem 44:368-371.
32. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Dimiceli S, Pitts T, Nguyen L, Yang J, Harper C, Thorpe D, Vermeer S, Young H, Hebert J, Lin A, Ferguson J, Chiotti C, Wiese-Slater S, Rogers T, Salmon B, Nicholas P, Petersen PB, Pingree C, McMahon W, Wong DL, Cavalli-Sforza LL, Kraemer HC, Myers RM (1999) A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 65:493-507.
33. Roman GC (2007) Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents. J Neurol Sci 262:15-26.
34. Sajdel-Sulkowska EM, Xu M, McGinnis W, Koibuchi N (2011) Brain regionspecific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum 10:43-48.
35. Schettler T (2006) Human exposure to phthalates via consumer products. Int J Androl 29:134-139.
36. Signorini C, De Felice C, Leoncini S, Giardini A, D'Esposito M, Filosa S, Della Ragione F, Rossi M, Pecorelli A, Valacchi G, Ciccoli L, Hayek J (2011) F(4)-neuroprostanes mediate neurological severity in Rett syndrome. Clin Chim Acta 412:1399-1406.
37. Silva MJ, Barr DB, Reidy JA, Kato K, Malek NA, Hodge CC, Hurtz D, Calafat AM, Needham LL, Brock JW (2003a) Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch Toxicol 77:561-567.
38. Silva MJ, Malek NA, Hodge CC, Reidy JA, Kato K, Barr DB, Needham LL, Brock JW (2003b) Improved quantitative detection of 11 urinary phthalate metabolites in humans using liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatog 789:393-404.
39. Suzuki Y, Niwa M, Yoshinaga J, Mizumoto Y, Serizawa S, Shiraishi H (2010) Prenatal exposure to phthalate esters and PAHs and birth outcomes. Environ Int 36:699-704.
40. U.S. FDA (Food and Drug Administration) (2011) Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. Available online at http://www.fda.gov/downloads/MedicalDevices/Device-RegulationandGuidance /GuidanceDocuments/UCM080457.pdf (accessed 22 September 2011).
41. Villagonzalo KA, Dodd S, Dean O, Gray K, Tonge B, Berk M (2010) Oxidative pathways as a drug target for the treatment of autism. Expert Opin Ther Targets 14:1301-1310.
42. Weintraub K (2011) The prevalence puzzle: autism counts. Nature 479:22-24.
43. Whyatt RM, Liu X, Rauh VA, Calafat AM, Just AC, Hoepner L, Diaz D, Quinn J, Adibi J, Perera FP, Factor-Litvak P (2011) Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor and behavioral development at age three years. Environ Health Perspect 120: 290-295.
44. Wittassek M, Angerer J (2008) Phthalates: metabolism and exposure. Int J Androl 31:131-138.
45. Wittassek M, Angerer J, Gehring K, Schäfer SD, Klockenbusch W, Dobler L, Günsel AK, Müller A, Wiesmüller GA (2009) Fetal exposure to phthalates - a pilot study. Int J Hyg Environ Health 212:492-498.
46. Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K (2006) What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal 26:803-824.